Researchers are exploring delivering super-specific AAVs through the brain's natural waste disposal system, which can carry ...
The anti-amyloid drug is designed for a limited course, where patients can stop treatment once they reach a level of ...
The focus on treating people who have no cognitive impairment raises questions about how to implement testing for those at ...
NEW YORK – The US Food and Drug Administration has cleared Umoja Biopharma to begin a Phase I/II trial for its CD22-directed in vivo CAR T-cell therapy, UB-VV400, in patients with relapsed or ...
NEW YORK – Telix Pharmaceuticals has opened a new radiopharmaceutical manufacturing and treatment facility in Melbourne, Australia, the company announced Thursday.
After a promising Phase I read out on mKRAS-VAX in patients with hereditary cancer predisposition and pancreatic lesions, ...
ATR 1072, a small interfering RNA drug, is Atrium's first precision cardiology program to enter the clinic since its launch earlier this year.
In an investigator-initiated trial, researchers will evaluate TPST-4003 in autoimmune disorders like myasthenia gravis and multiple sclerosis.
Primary care docs in Sweden diagnosed Alzheimer's with the same accuracy as dementia specialists when they had access to beta ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results